ORAL WIRKSAME VASODILATOREN BEI DER CHRONISCHEN THERAPIERESISTENTEN HERZINSUFFIZIENZ. WIRKUNGSVERGLEICH VON ISOSORBIDDINITRAT, PRAZOSIN UND DIHYDRALAZIN

Translated title of the contribution: Orally active vasodilators in the management of chronic-resistant cardiac failure

A. Wirtzfeld, G. Klein, F. C. Himmler, G. Schmidt, I. Kutschera, E. Sauer

Research output: Contribution to journalArticlepeer-review

Abstract

The acute haemodynamic effects of 40 mg isosorbide dinitrate (10 subjects), 4 mg prazosin (20 subjects) and 50 mg dihydralazine (8 subjects) were compared in 24 patients with the clinical picture of chronic therapy-resistant cardiac failure (NY Heart Association stages III-IV). There was a fall in left-ventricular filling pressure of about 15% and right-atrial mean pressure of 21 and 24%, respectively, with isosorbide dinitrate and prazosin, while there was no change with dihydralazine. Cardiac output rose by 23% with dihydralazine and 20% with prazosin, but remained unchanged with isosorbide dinitrate. These data indicate that a reduction in pulmonary and systemic-venous congestion due to chronic decompensated cardiac failure can be achieved with isosorbide dinitrate and prazosin, while cardiac output can be improved only with prazosin and dihydralazine.

Translated title of the contributionOrally active vasodilators in the management of chronic-resistant cardiac failure
Original languageGerman
Pages (from-to)1379-1383
Number of pages5
JournalDeutsche Medizinische Wochenschrift
Volume105
Issue number40
DOIs
StatePublished - 1980

Fingerprint

Dive into the research topics of 'Orally active vasodilators in the management of chronic-resistant cardiac failure'. Together they form a unique fingerprint.

Cite this